Literature DB >> 8822925

The tissue-specific transcriptional regulation of the megakaryocytic glycoprotein IIb gene is controlled by interactions between a repressor and positive cis-acting elements.

M H Prandini1, F Martin, D Thevenon, G Uzan.   

Abstract

Much information on regulation of the transcription of megakaryocytic genes stems from studies on the glycoprotein IIb (GPIIb) gene, an early and specific marker of this lineage. Transcriptional activity is controlled by the association of positive promoter elements corresponding to binding sites for the transcription factor GATA-1 and a member of the Ets family. In the present study, we show that these elements are not directly involved in the control of cell specificity. In contrast, we identified a sequence located between -170 and -73 that exhibited a repressor activity based on an analysis of the transcriptional activity of 5'-deleted GPIIb promoter fragments transfected in the nonhematopoietic HeLa cells. Further analysis of this repressor by substitution mutagenesis of the -139/-63 region showed that bases -120/-116 and -102/-93 were required for full repressor activity. The repressor is able to interact differentially with GPIIb promoter elements active in the megakaryocytic HEL, the erythroid K562, the monocytic U937, or the nonhematopoietic HeLa cell lines, indicating that it controls GPIIb gene tissue specificity. In addition, direct evidence for tissue-specific interaction between this repressor and the GPIIb -598/ -406 enhancer was obtained when these elements were set in the context of a heterologous SV40 promoter. Interestingly, the same repressor element controlling tissue specificity of the GPIIb gene may also control its temporal expression during megakaryocyte differentiation, based on recent evidence obtained by Fong and Santoro (J Biol Chem 269:18441, 1994). Finally, we found that the -120/-116 GPIIb sequence was part of a consensus motif shared by promoters of other megakaryocyte-specific genes, suggesting a common repressor mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822925

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs.

Authors:  Juan Fang; Eric S Jensen; Mary K Boudreaux; Lily M Du; Troy B Hawkins; Sevasti B Koukouritaki; Kenneth Cornetta; David A Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

2.  Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells.

Authors:  D A Wilcox; J C Olsen; L Ishizawa; M Griffith; G C White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 3.  Platelets as delivery systems for disease treatments.

Authors:  Qizhen Shi; Robert R Montgomery
Journal:  Adv Drug Deliv Rev       Date:  2010-07-07       Impact factor: 15.470

4.  Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

Authors:  Juan Fang; Kairbaan Hodivala-Dilke; Bryon D Johnson; Lily M Du; Richard O Hynes; Gilbert C White; David A Wilcox
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

5.  Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A.

Authors:  Lily M Du; Paquita Nurden; Alan T Nurden; Timothy C Nichols; Dwight A Bellinger; Eric S Jensen; Sandra L Haberichter; Elizabeth Merricks; Robin A Raymer; Juan Fang; Sevasti B Koukouritaki; Paula M Jacobi; Troy B Hawkins; Kenneth Cornetta; Qizhen Shi; David A Wilcox
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  MicroRNAs 10a and 10b Regulate the Expression of Human Platelet Glycoprotein Ibα for Normal Megakaryopoiesis.

Authors:  Zuping Zhang; Yali Ran; Tanner S Shaw; Yuandong Peng
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

7.  Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B.

Authors:  Dawei Wang; Xiaohu Shao; Qiang Wang; Xiaohong Pan; Yujun Dai; Shuxian Yao; Tong Yin; Zhugang Wang; Jiang Zhu; Xiaodong Xi; Zhu Chen; Saijuan Chen; Guowei Zhang
Journal:  Clin Transl Med       Date:  2021-03

Review 8.  The incredible journey: From megakaryocyte development to platelet formation.

Authors:  Kellie R Machlus; Joseph E Italiano
Journal:  J Cell Biol       Date:  2013-06-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.